Interferon in the treatment of chronic hepatitis C: a drug caught between past and future

By Vezali Elena   Aghemo Alessio   Colombo Massimo  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 3, 2011-03 ,pp. : 301-313

Informa Healthcare

Access to resources Recommend Favorite

Preliminary study of combination therapy with interferon-α and zinc in chronic hepatitis C patients with genotype 1b

By Nagamine Takeaki   Takagi Hitoshi   Takayama Hisashi   Kojima Akira   Kakizaki Satoru   Mori Masatomo   Nakajima Katuyuki  

Biological Trace Element Research, Vol. 75, Iss. 1-3, 2000-06 ,pp. : 53-63

Humana Press, Inc

Access to resources Recommend Favorite

Eicosapentaenoic Acid Supplementation for Chronic Hepatitis C Patients During Combination Therapy of Pegylated Interferon α-2b and Ribavirin

By Kawashima Aiko  

Lipids, Vol. 43, Iss. 4, 2008-04 ,pp. : 325-333

Springer Publishing Company

Access to resources Recommend Favorite

Serum zinc as a factor predicting response to interferon-α2b therapy in children with chronic hepatitis B

By Özbal Ebru   Helvaci Mehmet   Kasirga Erhun   Akdenizoglu Figen   Kizilgüneşler Asli  

Biological Trace Element Research, Vol. 90, Iss. 1-3, 2002-12 ,pp. : 31-38

Humana Press, Inc

Access to resources Recommend Favorite

Oxidative Status in Chronic Hepatitis C: The Influence of Antiviral Therapy and Prognostic Value of Serum Hydroperoxide Assay

By Morisco Filomena   Verde Veronica   Fogliano Vincenzo   Ritieni Alberto   Marmo Riccardo   De Luise Giusy   Tuccillo Concetta   Caporaso Nicola  

Free Radical Research, Vol. 38, Iss. 6, 2004-06 ,pp. : 573-580

Informa Healthcare

Access to resources Recommend Favorite